Pharmaceutical

ModeX wins $168m BARDA contract to develop viral antibody therapies

BARDA in the US has awarded a $168m Project NextGen grant to ModeX Therapeutics to develop anti-viral therapies.

Sep 29, 2023 - 20:00
ModeX wins $168m BARDA contract to develop viral antibody therapies
BARDA in the US has awarded a $168m Project NextGen grant to ModeX Therapeutics to develop anti-viral therapies.
Read the original article

Tags:

Previous Article

Karuna Therapeutics files for FDA approval for schizophrenia treatment

Next Article

Can reforms restore faith in India’s pharma industry after cough syrup scandals?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Senate panel clears PBM reforms, safety-net hospital payments

STAT+: Senate panel clears PBM reforms, safety-net hosp...

Nov 9, 2023

Rigosertib sodium by Traws Pharma for Epidermolysis Bul...

Apr 19, 2024

CD70 CAR-T by UTC Therapeutics for Relapsed Chronic Lym...

Aug 10, 2023